RTW INVESTMENTS, LP Diversified Active

CIK: 0001493215 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 18, 2016

Total Value ($000): $330,886 (100.0% shares, 0.0% debt)

Holdings (36)

ALNY Alnylam Pharmaceuticals Inc 19.4%
Value ($000) $64,275 Shares 948,286 Est. Cost $86.12 Unrealized -18.1%
Avexis Inc 10.3%
Value ($000) $34,039 Shares 825,980 Est. Cost $33.15 Unrealized
Agenus Inc 9.0%
Value ($000) $29,737 Shares 4,141,644 Est. Cost $7.65 Unrealized
La Jolla Pharmaceutical Co 8.4%
Value ($000) $27,838 Shares 1,170,151 Est. Cost $25.02 Unrealized
BCRX BioCryst Pharmaceuticals Inc 5.6%
Value ($000) $18,542 Shares 4,204,579 Est. Cost $7.25 Unrealized -44.9%
INCY Incyte Corp 5.4%
Value ($000) $18,024 Shares 191,151 Est. Cost $74.63 Unrealized +12.9%
Achillion Pharmaceuticals Inc 5.4%
Value ($000) $17,891 Shares 2,208,749 Est. Cost $10.21 Unrealized
Dicerna Pharmaceuticals Inc 3.6%
Value ($000) $11,918 Shares 2,026,894 Est. Cost $13.12 Unrealized
BMY Bristol-Myers Squibb Co 3.4%
Value ($000) $11,307 Shares 209,701 Est. Cost $48.14 Unrealized -4.1%
GLD SPDR Gold Trust 3.2%
Value ($000) $10,428 Shares 83,000 Est. Cost $126.47 Unrealized
Atara Biotherapeutics Inc. 3.0%
Value ($000) $9,799 Shares 458,113 Est. Cost $21.39 Unrealized
ARWR Arrowhead Pharmaceuticals Inc 2.5%
Value ($000) $8,208 Shares 1,116,777 Est. Cost $6.48 Unrealized 0.0%
HRTX Heron Therapeutics Inc 2.0%
Value ($000) $6,664 Shares 386,787 Est. Cost $18.55 Unrealized 0.0%
Viveve Medical Inc 1.8%
Value ($000) $6,060 Shares 839,274 Est. Cost $4.19 Unrealized
bluebird bio Inc 1.8%
Value ($000) $5,947 Shares 87,734 Est. Cost $43.60 Unrealized
Corium International Inc 1.8%
Value ($000) $5,888 Shares 1,045,747 Est. Cost $9.36 Unrealized
Invuity Inc 1.6%
Value ($000) $5,390 Shares 392,838 Est. Cost $13.24 Unrealized
Celldex Therapeutics Inc 1.5%
Value ($000) $5,022 Shares 1,243,164 Est. Cost $12.18 Unrealized
Medicines Co 1.4%
Value ($000) $4,642 Shares 123,000 Est. Cost $37.74 Unrealized
OMER Omeros Corp 1.3%
Value ($000) $4,274 Shares 383,012 Est. Cost $14.29 Unrealized -20.1%
TCMD Tactile Systems Technology Inc Cmn 1.3%
Value ($000) $4,256 Shares 227,599 Est. Cost $15.35 Unrealized 0.0%
Barclays Bank Plc 1.2%
Value ($000) $4,018 Shares 180,500 Est. Cost $22.17 Unrealized
RGNX Regenxbio Inc 1.0%
Value ($000) $3,345 Shares 238,740 Est. Cost $24.07 Unrealized -54.2%
Oxford Immunotec Global PLC 0.9%
Value ($000) $2,963 Shares 235,900 Est. Cost $12.56 Unrealized
Five Prime Therapeutics Inc 0.7%
Value ($000) $2,312 Shares 44,044 Est. Cost $22.81 Unrealized
Global Blood Therapeutics Inc 0.7%
Value ($000) $2,206 Shares 95,714 Est. Cost $35.72 Unrealized
MASI Masimo Corp 0.5%
Value ($000) $1,541 Shares 25,900 Est. Cost $40.86 Unrealized +38.1%
NOVAVAX INC 0.3%
Value ($000) $996 Shares 4,787 Est. Cost Unrealized
Mirati Therapeutics Inc 0.3%
Value ($000) $854 Shares 129,129 Est. Cost $33.11 Unrealized
SRTS Sensus Healthcare Inc Cmn 0.2%
Value ($000) $773 Shares 125,700 Est. Cost $6.26 Unrealized 0.0%
Biopharmx Corp 0.1%
Value ($000) $389 Shares 700,636 Est. Cost $1.87 Unrealized
Audentes Therapeutics Inc 0.1%
Value ($000) $356 Shares 20,000 Est. Cost $17.80 Unrealized
NTRA Natera Inc 0.1%
Value ($000) $352 Shares 31,693 Est. Cost $16.90 Unrealized -33.3%
MANNKIND CORP 0.1%
Value ($000) $272 Shares 4,385 Est. Cost Unrealized
Nivalis Therapeutics Inc 0.1%
Value ($000) $244 Shares 30,000 Est. Cost $15.17 Unrealized
Abeona Therapeutics Inc 0.0%
Value ($000) $116 Shares 19,391 Est. Cost $5.98 Unrealized